<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>News on Purdue Pharma Lp</title><link href="http://guidetoinsomnia.com/topic/purdue-pharma-lp" rel="alternate"></link><id>http://guidetoinsomnia.com/topic/purdue-pharma-lp</id><updated>2010-04-16T11:01:21Z</updated><entry><title>Transcept rises on Purdue sleep aid license</title><link href="http://guidetoinsomnia.com/insomnia/transcept-rises-purdue-sleep-aid-license-617995a" rel="alternate"></link><updated>2010-04-16T11:01:21Z</updated><author><name>AP News</name></author><id>tag:guidetoinsomnia.com,2010-04-16:/insomnia/transcept-rises-purdue-sleep-aid-license-617995a/</id><summary type="html">&lt;div id="subtitle"&gt;Transcept surges after company enters &lt;a title="United States" href="/topic/United+States" &gt;US&lt;/a&gt; sleep aid promotion agreement with &lt;a title="Purdue Pharma LP" href="/topic/Purdue+Pharma+LP" &gt;Purdue Pharma&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;p&gt;Shares of &lt;a title="Transcept Pharmaceuticals Inc." href="/topic/Transcept+Pharmaceuticals+Inc." &gt;Transcept Pharmaceuticals Inc.&lt;/a&gt; rocketed Monday after the company said it licensed its insomnia treatment candidate Intermezzo to Purdue Pharmaceutical Pro...</summary><category term="Insomnia"></category><category term="Mental Health"></category><category term="United States"></category><category term="North America"></category><category term="Purdue University"></category><category term="Canada"></category><category term="Food and Drug Administration"></category><category term="Mexico"></category><category term="Ambien"></category><category term="Purdue Pharma LP"></category><category term="Sleeping and Sleep Disorders"></category><category term="Transcept Pharmaceuticals Inc."></category></entry></feed>
